This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Weinhold N, Johnson DC, Rawstron AC, Forsti A, Doughty C, Vijayakrishnan J et al. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood 2014; 123: 2513–2517.
Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020–2028.
Zhou Y, Zhang Q, Stephens O, Heuck CJ, Tian E, Sawyer JR et al. Prediction of cytogenetic abnormalities with gene expression profiles. Blood 2012; 119: e148–e150.
Tian E, Sawyer JR, Heuck CJ, Zhang Q, van RF, Barlogie B et al. In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes. Genes Chromosomes Cancer 2014; 53: 549–557.
Broderick P, Chubb D, Johnson DC, Weinhold N, Forsti A, Lloyd A et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat Genet 2012; 44: 58–61.
Chubb D, Weinhold N, Broderick P, Chen B, Johnson DC, Forsti A et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet 2013; 45: 1221–1225.
Erickson SW, Raj VR, Stephens OW, Dhakal I, Chavan SS, Sanathkumar N et al. Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma. Blood 2014; 124: 2001–2003.
Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood 2002; 99: 1745–1757.
Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M . Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013; 328: 198–206.
Lindsey-Boltz LA, Kemp MG, Reardon JT, DeRocco V, Iyer RR, Modrich P et al. Coupling of human DNA excision repair and the DNA damage checkpoint in a defined in vitro system. J Biol Chem 2014; 289: 5074–5082.
Annunziata CM, Hernandez L, Davis RE, Zingone A, Lamy L, Lam LT et al. A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. Blood 2011; 117: 2396–2404.
Rouse M, Younes A, Egan JM . Resveratrol and curcumin enhance pancreatic beta-cell function by inhibiting phosphodiesterase activity. J Endocrinol 2014; 223: 107–117.
Gomez-Bougie P, Halliez M, Maiga S, Godon C, Kervoelen C, Pellat-Deceunynck C et al. Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups. Cancer Biol Ther 2015; 16: 60–65.
Acknowledgements
This study received financial support from the National Institutes of Health (NIH)/National Institute of Nursing Research (NINR) 5RC2NR011945 as primary support, UAMS Translational Research Institute at University of Arkansas for Medical Sciences (UAMS; grant 1UL1RR029884), the Elizabeth Stanley Cooper Chair in Oncology Nursing, the Research Fund at Region Sjaelland, Denmark, the Danish Cancer Society, Denmark; Familien Hede Nielsens Fund, Denmark; the Dagmar Marshall fund, Denmark, and the UAMS Medical Research Foundation.
Author contributions
SWE, CJH and AJV conceived and designed the research, interpreted results and wrote the manuscript. OWS and SWC collected and verified clinical and gene expression profiling data. SWE performed the statistical analysis. ET, JE and BB interpreted results and edited the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Erickson, S., Stephens, O., Chavan, S. et al. Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma. Leukemia 29, 2418–2421 (2015). https://doi.org/10.1038/leu.2015.238
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.238